PERSPECTA

News from every angle

← Back to headlines

ResMed Downgraded by RBC Capital Markets Amid FY27 Challenges

ResMed has been downgraded by RBC Capital Markets, citing challenges anticipated for the company in fiscal year 2027.

16 Jul, 17:00 — 16 Jul, 17:00
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed26d ago

ResMed downgraded at RBC Capital Markets on FY27 challenges

Read full article →

Related Stories

Marex Group and Janus International Group Release Q2 2026 Earnings Previews/Summaries

37m ago

Rapid7 Shares Surge After Strong Q2 Earnings and Workforce Reduction

48m ago

Criminals Launder Money Using Pokémon Cards in Sweden

56m ago

Bumble Drops Women-First Chat Rule to Boost Engagement

56m ago